[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Exclamotite69 Avatar @Exclamotite69 Exclamotite

Exclamotite posts on X about $gmab, $crmd, $gentol, $xbranest the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence stocks XXXX% technology brands XXXX% finance XXXX% countries XXXX% automotive brands XXXX% cryptocurrencies XXXX%

Social topic influence $gmab 24.56%, $crmd 17.54%, $gentol 8.77%, $xbranest 7.02%, $siga 7.02%, crmd 7.02%, $googl 5.26%, $resmi 5.26%, $autl 3.51%, $adma XXXX%

Top accounts mentioned or mentioned by @investseekers @hiteshkar @meeijer @shantaram83 @returnsjourney @salins99 @taobanker @dersimsylwan @qualitystocksa @kyleadamsstocks @stocklogging @skeptical1704 @atriumresearch @equitybaron @mvcinvesting @charlyai @ridingwaves69 @kiarakeira96188 @blinklebloop @maxwellhouse99

Top assets mentioned Alphabet Inc Class A (GOOGL) ADMA Biologics, Inc. (ADMA) Tesla, Inc. (TSLA) Nebius Group N.V. Class A Ordinary Shares (NBIS) Mind (MND) Catalyst Pharmaceutical Inc. (CPRX) TransMedics Group, Inc. Common Stock (TMDX)

Top Social Posts #

Top posts by engagements in the last XX hours

"@DersimSylwan They have a competitive advantage in production of antibodies: they use procaryotes instead of eucaryotes (it's cheaper). They aren't the only ones but it remains an edge. They will launch soon the biosimillar of Lucentis in the USA. Best-case scenario: Hanza becomes a fastgrower"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-22 20:32:54 UTC XXX followers, XX engagements

"Top X holding: - $GMAB Genmab: biotech stalwart/fast grower - $GENT.OL Gentian Diagnostics: medtech fast grower - $CRMD CorMedix: pharma/medtech fast grower - $XBRANE.ST Xbrane Biopharma: biotech turnaround - $AUTL Autolus Therapeutics: biotech fast grower"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-01 09:56:37 UTC XXX followers, XXX engagements

"Too many opportunities in Healthcare it's amazing - Genmab - $GMAB - CorMedix - $CRMD (I added more today at $12.80) - ADMA Biologics - $ADMA (added at $18.20) - Xbrane - $XBRANE.SE : a VERY interesting turnaround case with a HUGE upside (but it could also go to 0)"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-06-27 15:48:29 UTC XXX followers, XXX engagements

"@ReturnsJourney The current opportunities are not in pure techs but in bio and medtechs This sector is undervalued. Few names: - CorMedix $CRMD - GenMab $GMAB - Xbrane $XBRANE this one is a speculative turnaround"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-06-28 12:35:02 UTC XXX followers, XXX engagements

"@Quality_stocksA $GOOGL (I own this stock) and $TSLA (I love this company)"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-20 16:33:03 UTC XXX followers, XXX engagements

"@equitybaron Thanks this one is in the PF of William Higgons the French Buffett. I own $RES.MI (Recupero Etico Sostenibile) a beautifull familial company operating in waste recycling. A perfect Lynch stock completly under the radar"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-18 10:49:55 UTC XXX followers, XX engagements

"@investseekers Wonderful Gem-mab So undervalued"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-17 08:51:02 UTC XXX followers, XX engagements

"@shantaram83 Haha fortunately I dont have any of these stocks In healthcare I definitely prefer $CRMD and $GMAB And $SIGA as a hedge against World War III"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-13 22:12:39 UTC XXX followers, XXX engagements

"@KyleAdamsStocks 1) $GMAB Genmab 2) $GENT.OL Gentian Diagnostics 3) $CRMD CorMedix 4) $DCTH Delcath Systems 5) $AUTL Autolus Therapeutics"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-06-06 22:46:17 UTC XXX followers, XXX engagements

"@investseekers It was an overreaction of the market. It was just an early candidate in the pipeline not a big deal. I liked that the management decided to stop development. Genmab's capital allocation is impressive and Epkinly+Rina-S are best-in-class products"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-06-17 15:39:21 UTC XXX followers, XXX engagements

"@meeijer $GOOGL. I also own $NBIS but the current price is too expensive"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-20 09:46:18 UTC XXX followers, XXX engagements

"@ReturnsJourney . and if these X candidates failed to be successfull Genmab would have enough cash to imediatly buy another advanced candidate. And maybe another one in X or X years. At the current price we only buy the commercialized drugs and we get the pipeline for free"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-06 11:01:10 UTC XXX followers, XX engagements

"New buys in June: - $XBRANE.ST - $MIND Mind Technology: Oil&Gas provider late turnaround - $RES.MI Recupero Etico Sostenibile: industrial micro-stalwart/fast grower - $ADMA ADMA Biologics: biotech fast grower"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-01 10:04:32 UTC XXX followers, XXX engagements

"@ReturnsJourney Its main drug (Darzalex 2/3 of the sales but the proportion is decreasing due to the launch of new products) will lose its patent around 2029. Other pharmas have the same issue. I am confident in Genmab to find new growth drivers. There are X drugs in its advanced pipeline"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-06 10:57:28 UTC XXX followers, XXX engagements

"Day Trading for fun: I sold my position in $TPG.DE (The Platform Group only XXXX% of my PF) to buy a few shares of $GMAB (Genmab). J&J will publish Darzalex sales today ($GMAB earns around XX% royalties from this one) and I expect it will be a catalyst to propel the SP of $GMAB"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-16 10:22:41 UTC XXX followers, XXX engagements

"@DersimSylwan It's a turnaround. They were near to bankruptcy few months ago. They successfully divested some activities and then raised capital recently. Now they don't have any debt and a good runway. They hope to breakeven in the next quarters"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-22 20:29:51 UTC XXX followers, XX engagements

"@Ridingwaves69 It seems undervalued like $GMAB (Genmab)"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-03 17:39:23 UTC XXX followers, XX engagements

"@KiaraKeira96188 Hi what could be the impact of this news"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-07 11:44:06 UTC XXX followers, XX engagements

"Current Portfolio. Top 5: - $CRMD CorMedix - $GMAB Genmab - $GENT.OL Gentian Diagnostics - $XBRANE.ST Xbrane Biopharma - $ALDOC.PA Omer-Degugis et Cie"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-07 22:19:46 UTC XXX followers, 2110 engagements

"@meeijer Not the best upside but $SIGA is an assymetric bet. Phama company selling a drug against spox/mpox to the governments (prevention of bioterrorism). Contract with BARDA to be renewed in 2025: - if huge contract: x-bagger; - if not: still a cheap cow cash high-dividend yield (8%)"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-22 12:45:10 UTC XXX followers, XXX engagements

"@meeijer I own $GOOGL but I just expect an increase of the PER from XX to XX and a CAGR of the EPS of 10%"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-20 23:15:39 UTC XXX followers, XX engagements

"@salins99 @shantaram83 $CRMD CorMedix $GMAB Genmab $DCTH Delcath (not in my PF) $SIGA Siga (hedge in case of war) $COV.V Covalon $HANZA.OL Hanza (very intersting turnaround under the radar) $GENT.OL Gentian Diagnostics"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-13 23:03:02 UTC XXX followers, XXX engagements

"@taobanker $CPRX reminds me Genmab but with a better long term trend Thanks"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-03 17:31:28 UTC XXX followers, XXX engagements

"@maxwellhouse99 $CRMD CorMedix $GMAB Genmab $SIGA Siga"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-22 00:42:04 UTC XXX followers, XXX engagements

"The valuation of Genmab ($GMAB) is insane Very good entry point"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-06-26 13:14:59 UTC XXX followers, XXX engagements

"$GMAB I'm not a big fan of technical analysis but it's the only way to explain Genmab's dip after a series of positive news releases. It seems there is a good entry point. It's undervalued. By far"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-06-24 16:56:13 UTC XXX followers, XXX engagements

"Current PF. Top 5: - $GMAB Genmab - $CRMD CorMedix - $GENT.OL Gentian Diagnostics - $RES.MI Recupero Etico Sostenibile - $XBRANE.ST Xbrane Biopharma"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-12 00:30:19 UTC XXX followers, XXX engagements

"That's exactly what $GMAB (Genmab) is doing. I love this management"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-07 22:29:50 UTC XXX followers, XXX engagements

"@meeijer $XXX for $TMDX seems very high all the future growth is already priced $250-$300 would be more realistic"
@Exclamotite69 Avatar @Exclamotite69 on X 2025-07-20 23:13:47 UTC XXX followers, 1105 engagements